Loading data
IVFNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6.84 m USD | 6.56 m USD | 3.02 m USD | 822.2 k USD | 4.16 m USD |
| Cost of revenue | 30.57 k USD | 3.72 m USD | 1.97 m USD | 331.52 k USD | 145.05 k USD |
| Gross profit | — | — | — | 490.67 k USD | 4.02 m USD |
| Research and development expense | — | 4.88 k USD | 165.95 k USD | 544.04 k USD | 216.43 k USD |
| Selling, general and administrative expense | 7.69 m USD | 8.07 m USD | 7.49 m USD | 9.98 m USD | 9.02 m USD |
| Operating profit | -7.24 m USD | -6.63 m USD | -6.77 m USD | -10.63 m USD | -5.22 m USD |
| Interest expense | — | 1.06 m USD | 925.91 k USD | 59.45 k USD | 1.27 m USD |
| Profit before tax | -5.49 m USD | -7.6 m USD | -8.01 m USD | -10.89 m USD | -6.65 m USD |
| Income tax expense | -150.37 k USD | 140.2 k USD | 27.79 k USD | 2.87 k USD | 4.76 k USD |
| Net income (reported basis) | 23.32 m USD | 9.05 m USD | 8.03 m USD | -10.89 m USD | -6.65 m USD |
| Net income attributable to common shareholders | -25.13 m USD | -9.51 m USD | -8.03 m USD | — | — |
| Basic earnings per share | -214.64 USD/share | -3,782.65 USD/share | -67.37 USD/share | -17.97 USD/share | -0.63 USD/share |
| Diluted earnings per share | -214.64 USD/share | -3,782.65 USD/share | -67.37 USD/share | -17.97 USD/share | -0.63 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.